A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Seagen, Astellas and Merck announce FDA has accepted biologics license applications for PADCEV and KEYTRUDA for first-line treatment of certain urothelial cancers
Published: December 21, 2022 by ENP Newswire
Roche announces FDA approval of Actemra intravenous infusion for treatment of COVID-19 in hospitalized adults; product is first monoclonal antibody approved by the FDA for COVID-19
Published: December 21, 2022 by GlobeNewswire Europe
GSK updates prescribing information for the ovarian cancer drug Zejula, limiting use to second-line maintenance therapy only to patients with certain mutation types; change was made at the request of FDA following review of Phase 3 clinical results
Published: November 14, 2022 by PharmaBiz (India)
AstraZeneca and Daiichi Sankyo’s Enhertu injection recommended for approval in the EU as a treatment for certain type of gastric cancer; drug is currently approved in the US
Published: November 14, 2022 by AstraZeneca AB
AstraZeneca’s Imfinzi recommended in the EU for approval as a first-line treatment for unresectable or metastatic biliary tract cancer; treatment is used in combination with chemotherapy
Published: November 14, 2022 by AstraZeneca AB

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count